CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $62.56, moving -2.51% from the previous trading session. Elsewhere, the Dow saw a downswing of 0.16%, while the tech-heavy Nasdaq ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...

In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Mr Andrews contacted the medical team at Massachusetts General Hospital ( MGH) that had carried out the operation. On January ...

Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.